Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level
This suggests a broader swath of patients could be included in Lp(a)-lowering studies and potentially benefit from these agents.
Source: tctmd.com
Stay updated with breaking news from Aeron Small. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This suggests a broader swath of patients could be included in Lp(a)-lowering studies and potentially benefit from these agents.